1. Home
  2. AHMA vs SCYX Comparison

AHMA vs SCYX Comparison

Compare AHMA & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AHMA

Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares

HOLD

Current Price

$1.37

Market Cap

49.3M

ML Signal

HOLD

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$5.28

Market Cap

51.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHMA
SCYX
Founded
2007
1999
Country
United Arab Emirates
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.3M
51.1M
IPO Year
2024
2014

Fundamental Metrics

Financial Performance
Metric
AHMA
SCYX
Price
$1.37
$5.28
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
34.3K
109.4K
Earning Date
05-22-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.36
EPS
N/A
N/A
Revenue
N/A
$257,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$608.78
P/E Ratio
$180.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$0.57
52 Week High
$39.50
$6.09

Technical Indicators

Market Signals
Indicator
AHMA
SCYX
Relative Strength Index (RSI) 39.12 57.13
Support Level $1.03 $4.65
Resistance Level $1.88 $5.56
Average True Range (ATR) 0.10 0.37
MACD -0.01 -0.01
Stochastic Oscillator 21.43 41.30

Price Performance

Historical Comparison
AHMA
SCYX

About AHMA Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares

Ambitions Enterprise Management Co LLC, through its subsidiaries in the UAE, operates as a tour operator, travel agency, and event planning and management services provider. It provides two lines of services, namely, MICE management, a comprehensive coordination and organization of events, and one-stop tourism, a comprehensive travel product that is designed to provide tourists with all the necessary components of a trip in a single and convenient package, which typically include transportation, accommodations, meals, and guided tours or activities.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: